Emergent BioSolutions (EBS) Prepaid Assets (2010 - 2026)
Emergent BioSolutions (EBS) recorded quarterly Prepaid Assets of $26.9 million in Q1 2026, up 4.26% quarter-over-quarter from $25.8 million in Q4 2025, and down 10.93% on a YoY basis from $30.2 million in Q1 2025.
Emergent BioSolutions (EBS) Prepaid Assets (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Prepaid Assets history runs 17 years deep, the most recent figure standing at $26.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 10.93% year-over-year to $26.9 million; the TTM figure through Mar 2026 stood at $26.9 million (down 10.93% YoY), while the FY2025 annual figure was $25.8 million, down 4.09% from the prior year.
- Prepaid Assets was $26.9 million for Q1 2026 at Emergent BioSolutions, up from $25.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $139.9 million in Q3 2022 to a low of $24.0 million in Q2 2025.
- Historically, Prepaid Assets has averaged $52.6 million across 5 years, with a median of $41.7 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 93.84% in 2022, then slumped 64.35% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $57.9 million in 2022, then decreased by 17.27% to $47.9 million in 2023, then tumbled by 43.84% to $26.9 million in 2024, then slipped by 4.09% to $25.8 million in 2025, then advanced by 4.26% to $26.9 million in 2026.
- The last three Prepaid Assets figures came in at $26.9 million (Q1 2026), $25.8 million (Q4 2025), and $25.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Emergent BioSolutions | 415.46 Mn | 253.96 Mn | 84.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.90 Mn |
| Dec 31, 2025 | 25.80 Mn |
| Sep 30, 2025 | 25.60 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | 30.20 Mn |
| Dec 31, 2024 | 26.90 Mn |
| Sep 30, 2024 | 61.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Mar 31, 2024 | 36.50 Mn |
| Dec 31, 2023 | 47.90 Mn |
| Sep 30, 2023 | 62.40 Mn |
| Jun 30, 2023 | 44.70 Mn |
| Mar 31, 2023 | 41.70 Mn |
| Dec 31, 2022 | 57.90 Mn |
| Sep 30, 2022 | 139.90 Mn |
| Jun 30, 2022 | 125.40 Mn |
| Mar 31, 2022 | 81.80 Mn |
| Dec 31, 2021 | 70.20 Mn |
| Sep 30, 2021 | 88.30 Mn |
| Jun 30, 2021 | 66.10 Mn |